bifurcation stenting with bvs · bifurcation stenting with bvs maciej lesiak department of...
TRANSCRIPT
Bifurcation stenting with BVS
Maciej Lesiak Department of Cardiology
University Hospital in Poznan, Poland
Breaking the limits or just breaking the struts?
Disclosure
Speaker’s name: Maciej Lesiak
I have the following potential conflicts of interest to this
presentation:
Research contracts
Consulting: Abbott Vascular
Employment in industry
Stockholder of a healthcare company
Owner of a healthcare company
Other(s)
Background
• BVS is a promising technology (vessel reparative therapy)
• Scaffolds have not been tested in bifurcation lesions so far
• Is coronary artery bifurcation an important limitation in the use of BVS?
Kissing with two NC balloons (3.0 & 2.5 mm) @ 8 ATM
BVS 3.0x18 mm Silicone tube, lumen 3.0 mm
No ruptured links
3.0
NC 2.5
BVS 3.0 x 18 mm NC 3.0 BVS 3.0 x 18 mm
3.52 mm
Poznan Bifurcation BVS Registry
• Consecutive bifurcation cases treated with BVS
• Informed consent
• Any indication to PCI (stable or ACS)
• Any Medina type
• No excessive calcium & tortuosity
Inclusion / exclusion criteria
Prospective, single-centre clinical registry
Baseline characteristics N = 43
Age (years) 62± 11
Male gender 33 (77%)
Diabetes mellitus 14 (32.6%)
Hypertension 33 (76.7%)
Smoking 20 (46.5%)
Previous MI 22 (52.4%)
LV Ejection Fraction (%) 51 ± 11
Previous revascularization 24 (55,8%)
Peripheral vascular disease 4 (9.3%)
Chronic Kidney Disease (eGFR<60) 6 (14.0%)
Indication for PCI
Stable angina 33 (76.7%)
Unstable angina / NSTEMI 7 (16.5%)
STEMI 3 (7.0%)
Total population
Vessel / Lesion characteristics N = 43
Bifurcation location
LM/LAD, LM/LCx 7 (16.3%)
LAD/DIA 25 (58.1%)
LCX/OM 9 (20.9%)
RCA (PL/PDA) 2 (4.7%)
True bifurcation lesion: 1,1,1 / 1,0,1 / 0,1,1 20 (46.5%)
Ostial SB only (0,0,1) 8 (18.6%)
Type B2+C 36 (83.7%)
Calcification (moderate/heavy) 10 (27%)
Thrombus (angio) 4 (9.3%)
CTO 7 (16.3%)
Vessel / lesion
Procedure characteristics N = 43
Radial approach 30 (70%)
6 F Guiding catheter 43 (100%)
Simple technique (one stent) 37 (86%)
Provisional T stenting 30 (70%)
Systematic T stenting 4 (9%)
TAP technique 1 (3%)
SB ostial stenting 8 (19%)
Pre dilatation 42(98%)
Strut opening 13 (35%)
Final Kissing / snuggle 13 (30%)
FK MB balloon diameter 3.0 ± 0.2 mm
FK SB balloon diameter 2.4 ± 0.2 mm
Results
Vessel / Lesion characteristics N = 43
Main Vessel
Reference vessel diameter prox. 3.2 ± 0.7 mm
Reference vessel diameter dist. 2.7 ± 1.0 mm
Lesion length (mm) 11.8 ± 8.8 mm
Diameter stenosis (%) 72 ± 27 %
Side Branch
Reference vessel diameter 2.4 ± 0.5 mm
Lesion length 5.1 ± 5.4 mm
Diameter stenosis 39.6 ± 31.4 %
Angles
Proximal bifurcation angle (angle A) 140 ± 40 degrees
Distal bifurcation angle (angle B) 54± 30 degrees
Bifurcation angle < 50 degrees 26 (60.5%)
Results
Procedure characteristics N = 43
MB Stent diameter 3.1 ± 0.2 mm
MB Stent length 21 ± 4.6 mm
SB Stent diameter 2.8 ± 0.4 mm
SB Stent length 21 ± 4.4 mm
Additional stenting
MB / SB 3 / 0
Scaffold/procedure success 43 / 42*
Fluoroscopy time 10.9 ± 6.7 min
Contrast use 145 ± 57 ml
IVUS / OCT 13 (30%)
Results
*One case of SB dissection during wire re-cross, slow flow, CKMB
In hospital Discharge-30 days
Death 0 1 (fatal stroke)
Cardiac death 0 0
Myocardial infarction 2 0
Q MI 0 0
Non-Q MI 2* 0
Stroke 0 1
Stent thrombosis (any as of ARC) 0 0
Target vessel failure 0 0
Clinical outcomes
*One case of SB dissection during wire re-cross, slow flow, CKMB
One case of septal branch closure with CKMB
n=43 Discharge – end of FU
All cause death 1
Cardiac death 0
Myocardial infarction 0
Target lesion revascularization 0
Target vessel revascularization 0
Stent thrombosis (any as of ARC) 0
Target vessel failure 0
Follow-up
Median observation time 134 days (3 – 366)
Mean observation time 140 ± 98 days
Baseline characteristics and angiography
49YO man, stable angina class 3. Anterior MI & PCI of LAD in 2013
6 F Guide, femoral approach
Target vessel
Baseline characteristics and angiography
60 YO woman, stable angina class 2
6 F Guide, femoral approach
Target vessel